PATHWAY: mmu04931 Help
Entry
Name
Insulin resistance - Mus musculus (house mouse)
Description
Insulin resistance is a condition where cells become resistant to the effects of insulin. It is often found in people with health disorders, including obesity, type 2 diabetes mellitus, non-alcoholic fatty liver disease, and cardiovascular diseases. In this diagram multiple mechanisms underlying insulin resistance are shown: (a) increased phosphorylation of IRS (insulin receptor substrate) protein through serine/threonine kinases, such as JNK1 and IKKB, and protein kinase C, (b) increased IRS-1 proteasome degradation via mTOR signaling pathway, (c) decreased activation of signaling molecules including PI3K and AKT, (d) increase in activity of phosphatases including PTPs, PTEN, and PP2A. Regulatory actions such as oxidative stress, mitochondrial dysfunction, accumulation of intracellular lipid derivatives (diacylglycrol and ceramides), and inflammation (via IL-6 and TNFA) contribute to these mechanisms. Consequently, insulin resistance causes reduced GLUT4 translocation, resulting in glucose takeup and glycogen synthesis in skeletal muscle as well as increased hepatic gluconeogenesis and decreased glycogen synthesis in liver. At the bottom of the diagram, interplay between O-GlcNAcylation and serine/threonine phosphorylation is shown. Studies suggested that elevated O-GlcNAc level was correlated to high glucose-induced insulin resistance. Donor UDP-GlcNAc is induced through hexosamine biosynthesis pathway and added to proteins by O-GlcNAc transferase. Elevation of O-GlcNAc modification alters phosphorylation and function of key insulin signaling proteins including IRS-1, PI3K, PDK1, Akt and other transcription factor and cofactors, resulting in the attenuation of insulin signaling cascade.
Class
Human Diseases; Endocrine and metabolic disease
BRITE hierarchy
Pathway map
Ortholog table
Organism
Mus musculus (house mouse) [GN:
mmu ]
Gene
140491 Ppp1r3a; protein phosphatase 1, regulatory subunit 3A [KO:K07189 ]
53412 Ppp1r3c; protein phosphatase 1, regulatory subunit 3C [KO:K07189 ]
244416 Ppp1r3b; protein phosphatase 1, regulatory subunit 3B [KO:K07189 ]
228966 Ppp1r3d; protein phosphatase 1, regulatory subunit 3D [KO:K07189 ]
105651 Ppp1r3e; protein phosphatase 1, regulatory subunit 3E [KO:K07189 ]
18706 Pik3ca; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922 ] [EC:2.7.1.153 ]
18707 Pik3cd; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922 ] [EC:2.7.1.153 ]
74769 Pik3cb; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922 ] [EC:2.7.1.153 ]
18709 Pik3r2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649 ]
18708 Pik3r1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649 ]
18710 Pik3r3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649 ]
20848 Stat3; signal transducer and activator of transcription 3 [KO:K04692 ]
12702 Socs3; suppressor of cytokine signaling 3 [KO:K04696 ]
21937 Tnfrsf1a; tumor necrosis factor receptor superfamily, member 1a [KO:K03158 ]
18035 Nfkbia; nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha [KO:K04734 ]
18033 Nfkb1; nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 [KO:K02580 ]
19697 Rela; v-rel reticuloendotheliosis viral oncogene homolog A (avian) [KO:K04735 ]
20528 Slc2a4; solute carrier family 2 (facilitated glucose transporter), member 4 [KO:K07191 ]
19079 Prkab1; protein kinase, AMP-activated, beta 1 non-catalytic subunit [KO:K07199 ]
108097 Prkab2; protein kinase, AMP-activated, beta 2 non-catalytic subunit [KO:K07199 ]
19082 Prkag1; protein kinase, AMP-activated, gamma 1 non-catalytic subunit [KO:K07200 ]
241113 Prkag3; protein kinase, AMP-activated, gamma 3 non-catalytic subunit [KO:K07200 ]
108099 Prkag2; protein kinase, AMP-activated, gamma 2 non-catalytic subunit [KO:K07200 ]
26457 Slc27a1; solute carrier family 27 (fatty acid transporter), member 1 [KO:K08745 ] [EC:6.2.1.-]
26569 Slc27a4; solute carrier family 27 (fatty acid transporter), member 4 [KO:K08745 ] [EC:6.2.1.-]
26458 Slc27a2; solute carrier family 27 (fatty acid transporter), member 2 [KO:K08746 ] [EC:6.2.1.- 6.2.1.3 ]
26568 Slc27a3; solute carrier family 27 (fatty acid transporter), member 3 [KO:K08772 ] [EC:6.2.1.-]
26459 Slc27a5; solute carrier family 27 (fatty acid transporter), member 5 [KO:K08748 ] [EC:6.2.1.7 ]
225579 Slc27a6; solute carrier family 27 (fatty acid transporter), member 6 [KO:K08749 ]
110854 Ptpa; protein phosphatase 2 protein activator [KO:K17605 ]
20787 Srebf1; sterol regulatory element binding transcription factor 1 [KO:K07197 ]
20526 Slc2a2; solute carrier family 2 (facilitated glucose transporter), member 2 [KO:K07593 ]
22259 Nr1h3; nuclear receptor subfamily 1, group H, member 3 [KO:K08536 ]
22260 Nr1h2; nuclear receptor subfamily 1, group H, member 2 [KO:K08535 ]
170826 Ppargc1b; peroxisome proliferative activated receptor, gamma, coactivator 1 beta [KO:K17962 ]
19017 Ppargc1a; peroxisome proliferative activated receptor, gamma, coactivator 1 alpha [KO:K07202 ]
19013 Ppara; peroxisome proliferator activated receptor alpha [KO:K07294 ]
108155 Ogt; O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) [KO:K09667 ] [EC:2.4.1.255 ]
20525 Slc2a1; solute carrier family 2 (facilitated glucose transporter), member 1 [KO:K07299 ]
74343 Crtc2; CREB regulated transcription coactivator 2 [KO:K16333 ]
12912 Creb1; cAMP responsive element binding protein 1 [KO:K05870 ]
12913 Creb3; cAMP responsive element binding protein 3 [KO:K09048 ]
26427 Creb3l1; cAMP responsive element binding protein 3-like 1 [KO:K09048 ]
208647 Creb3l2; cAMP responsive element binding protein 3-like 2 [KO:K09048 ]
208677 Creb3l3; cAMP responsive element binding protein 3-like 3 [KO:K09048 ]
78284 Creb3l4; cAMP responsive element binding protein 3-like 4 [KO:K09048 ]
231991 Creb5; cAMP responsive element binding protein 5 [KO:K09047 ]
Compound
C00043 UDP-N-acetyl-alpha-D-glucosamine
C00352 D-Glucosamine 6-phosphate
C05981 Phosphatidylinositol-3,4,5-trisphosphate
C06156 alpha-D-Glucosamine 1-phosphate
Reference
Authors
Martins AR, Nachbar RT, Gorjao R, Vinolo MA, Festuccia WT, Lambertucci RH, Cury-Boaventura MF, Silveira LR, Curi R, Hirabara SM
Title
Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function.
Journal
Reference
Authors
Bouzakri K, Roques M, Gual P, Espinosa S, Guebre-Egziabher F, Riou JP, Laville M, Le Marchand-Brustel Y, Tanti JF, Vidal H
Title
Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes.
Journal
Reference
Authors
Choi K, Kim YB
Title
Molecular mechanism of insulin resistance in obesity and type 2 diabetes.
Journal
Reference
Authors
Ahmad F, Goldstein BJ
Title
Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus.
Journal
Reference
Authors
George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC, Soos MA, Murgatroyd PR, Williams RM, Acerini CL, Dunger DB, Barford D, Umpleby AM, Wareham NJ, Davies HA, Schafer AJ, Stoffel M, O'Rahilly S, Barroso I
Title
A family with severe insulin resistance and diabetes due to a mutation in AKT2.
Journal
Reference
Authors
Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JW, Meinders AE, Jazet IM
Title
Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions.
Journal
Reference
Authors
Morino K, Petersen KF, Shulman GI
Title
Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.
Journal
Reference
Authors
Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK
Title
Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.
Journal
Reference
Authors
Kim JA, Wei Y, Sowers JR
Title
Role of mitochondrial dysfunction in insulin resistance.
Journal
Reference
Authors
Steinberg GR, Michell BJ, van Denderen BJ, Watt MJ, Carey AL, Fam BC, Andrikopoulos S, Proietto J, Gorgun CZ, Carling D, Hotamisligil GS, Febbraio MA, Kay TW, Kemp BE
Title
Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling.
Journal
Reference
Authors
Ruderman NB, Saha AK, Vavvas D, Witters LA
Title
Malonyl-CoA, fuel sensing, and insulin resistance.
Journal
Reference
Authors
Saha AK, Kurowski TG, Colca JR, Ruderman NB
Title
Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol.
Journal
Reference
Authors
Blachnio-Zabielska AU, Koutsari C, Tchkonia T, Jensen MD
Title
Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance.
Journal
Reference
Authors
Larter CZ, Farrell GC
Title
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
Journal
Reference
Authors
Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J, Montminy M
Title
PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.
Journal
Reference
Authors
Slawson C, Copeland RJ, Hart GW
Title
O-GlcNAc signaling: a metabolic link between diabetes and cancer?
Journal
Reference
Authors
Ruan HB, Singh JP, Li MD, Wu J, Yang X
Title
Cracking the O-GlcNAc code in metabolism.
Journal
Reference
Authors
Muoio DM, Newgard CB
Title
Obesity-related derangements in metabolic regulation.
Journal
Reference
Authors
Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL
Title
Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity.
Journal
Related pathway
mmu00514 Other types of O-glycan biosynthesis
mmu00520 Amino sugar and nucleotide sugar metabolism
KO pathway
LinkDB
All DBs